BUFFALO, NY- January 3, 2024 – A new editorial paper was published in Oncotarget's Volume 14 on December 20, 2023, entitled, “Therapeutically harnessing cancer stem cell-derived exosomes.” In this ...
Deal represents Lonza’s entry into the human pluripotent stem cell market. Lonza signed a worldwide, exclusive licensing and supply agreement with California Stem Cell focused on the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback